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A B S T R A C T
Purpose: To investigate the association between genotype (methyl-CpG-binding protein 2 (MECP2 gene
mutation)) and epileptic seizure phenotype in Rett syndrome.
Methods: We used the British Isles Rett syndrome survey to identify 137 subjects with one of the nine
most frequent MECP2 gene mutations and invited their parents or carers to participate in a postal
questionnaire and telephone interview. The questionnaire recorded information about epileptic seizure
types, non-epileptic vacant spells and treatments. Two investigators conducted telephone interviews
and three epileptologists classiﬁed their epileptic seizures.
Results: 89 subjects (65%) responded. The epilepsy prevalence was 67%, and 74% had non-epileptic
vacant spells. The epilepsy prevalence within speciﬁc genotypes ranged from 47% (mutation C-terminal
deletion, downstream of the Transcription Repression Domain) to 100% (mutation p.R270X, c.808C>T).
The prevalence of non-epileptic vacant spells within genotypes ranged from 50% (mutation p.R306C,
c.916C>T) to 100% (mutation p.R106W, c.316C>T). The epileptologists differed considerably in their
classiﬁcation of events, particularly of non-epileptic vacant spells.
Conclusions: The large majority of people with Rett syndrome have epilepsy. Most have multiple epileptic
seizure types, although generalised tonic–clonic seizures are the most common. There were no signiﬁcant
clinical differences between genotypes. The clinical differentiation of non-epileptic vacant spells is difﬁcult.
Discordance in epileptic seizure classiﬁcation between clinicians suggests that caution is needed, since the
clinical history alone cannot adequately classify the epileptic seizure type in Rett syndrome.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Rett syndrome is a neurodevelopmental disorder seen almost
exclusively in females, and usually associated with mutation in the
methyl-CpG-binding protein 2 (MECP2) gene at Xq28.1 The
prevalence of the classic syndrome ranges from 1:10 000 to
1:15 000.2,3 The phenotype is often severe, with several characteris-
tic features including a period of loss of hand and verbal skills, severe
psychomotorretardation,stereotyped handmovements, truncaland
gait dyspraxia: there are also several potential comorbidities
including scoliosis, autonomic dysfunction and epilepsy.4,5
Epilepsy occurs in between 70%6–8 and 90%9 of individuals with
Rett syndrome. Epileptic seizures are commonly of multiple types,* Corresponding author. Tel.: +44 2920564457; fax: +44 2920555047.
E-mail address: basil.cardoza@wales.nhs.uk (B. Cardoza).
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doi:10.1016/j.seizure.2011.06.010including complex partial, atypical absence and generalised tonic–
clonic.10They usually start between early infancy and late childhood;
although often remitting with progressing age, they remain severe
and treatment resistant in a minority.11,12 After the teenage years,
the epilepsy severity tends to decrease, with lower epileptic seizure
frequency and relatively more partial-onset seizures.9
Epileptic seizure rates are highest in the 7–12 years age group
and lower in those with p.R294X, p.R255X mutations and C-
terminal mutations.13 Other studies have shown that MECP2
mutations most frequently associated with epilepsy were T158M
(74%) and R106W (78%), and less frequently R255X and R306C
(both 49%).14 Epileptic seizures frequently appear during the
regression stage, with an early onset predicting a more severe
course.15 The same study showed that brain-derived neurotrophic
factor (BDNF) Val/Met polymorphism was correlated with earlier
onset of epileptic seizures, whereas MECP2 type and location did
not inﬂuence epilepsy.15 Early onset of epileptic seizures has alsovier Ltd. All rights reserved.
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Met66 allele may protect against epileptic seizures, whereas
missense mutations in the MBD of MECP2 are more frequently
associated with early epileptic seizures.16 There is no signiﬁcant
relationship between the underlying mutation and the likelihood
of either drug-resistant epilepsy or abnormal electroencephalog-
raphy (EEG).11 Cases without a detectable MECP2 mutation had a
higher risk of epileptic seizure onset up to 4 years of age, but a
lower risk after 4 years.17 Epilepsy differs among the various
phenotypes and genotypes with respect to age at onset, drug
responsiveness, and epileptic seizure semiology.18 Infantile
spasms, early-onset intractable epilepsy, and a Rett syndrome
like phenotype have also been associated with mutations in the
cyclin-dependent kinase-like 5 (CDKL5) gene in Xp22.13.19,20
Ambulation, hand use and language dysfunction also vary with
the underlying mutation; such abnormalities are fewer in those
with the R133C mutation, and greater in those with the R168X
mutation. In contrast, those with carboxy-terminal truncations are
more likely to walk and use words.21 Individuals with epileptic
seizures had greater overall clinical severity, and greater im-
pairment of ambulation, hand use, and communication.14 Signiﬁ-
cant differences by mutation are seen for individual phenotypic
characteristics such as hand use, ambulation, and language, with
p.R270X and p.R255X being the most severe, and p.R133C and
p.R294X being the mildest mutations.22
Myoclonic jerks and myoclonic status epilepticus are some-
times difﬁcult to distinguish clinically from movement disorders
such as the hand stereotypies, tremor, and dystonia of Rett
syndrome.23,24 Many events presumed to be epileptic seizures
have no EEG correlate during video-EEG monitoring.25 On the
other hand, EEG epileptiform activity commonly occurs without
overt clinical epileptic seizures. The intermittent EEG abnormality
and behavioural changes indicate abnormal ﬂuctuating arousal,
possibly of midbrain or brainstem origin.5,6
Epileptic seizures have a negative impact on the lives of many
children and their families. This is especially so in patients with
generalized, prolonged, cyanotic and drug-resistant epileptic sei-
zures.26Non-epileptic ‘‘Rettepisodes’’ (or non-epilepticvacantspells)
can be mistaken by observers, parents or professionals for epileptic
seizures and some ‘‘genuine’’ epileptic seizures may not be noticed.
These non-epileptic vacant spells) can include motor activity, such as
twitching, jerking, head turning, falling forward, and trembling, as
well as staring, laughing, pupil dilatation, breath holding and
hyperventilation.27 Breath holding may include expiratory apnoea
after hyperventilation, reﬂex expiratory apnoea, inspiratory apnoea,
apnoea or hypoventilation not otherwise speciﬁed.
Abnormal brainstem activity might cause behaviours that could
be confused with epileptic seizures, such as eye blinking, facial
twitching, vacant spells without EEG epileptiform activity, and
cyanosis.28 Irregular breathing is also characteristic29 and Rett
syndrome is regarded a cause of congenital dysautonomia.
Abnormal awake breathing is common and over 70% have either
hyperventilation or breath holding. Up to thirteen types of
abnormal breathing have been described, sometimes with several
being displayed sequentially in the same person.30 Ventilatory and
autonomic monitoring has demonstrated reduced resting vagal
tone with episodes of central autonomic instability.30
This study aimed to determine the type and frequency of
epileptic seizures and non-epileptic vacant spells in Rett syn-
drome, and any association of these features with the type of
MECP2 mutation.
2. Methods
The study was approved by the Multicentre Research Ethics
Committee for Wales, UK. We sent letters inviting participation tothe parents or carers of 137 patients known to the British Isles Rett
Syndrome Survey (BIRSS), each having one of the nine most
frequent mutations in the MECP2 gene (comprising 75% of all
known Rett-associated mutations). Parents or their carers gave
informed consent to the research and to publication of the results.
We developed a questionnaire to record information about
epileptic seizures and autonomic events, and mailed this to
participants; we sent a single reminder to non-responders. Two
investigators collected further detailed information using semi-
structured telephone interviews across the UK and the Republic of
Ireland.
2.1. Seizure validation
Three experienced epileptologists analysed the written seizure
descriptions obtained from clinical telephone interview. One was
an adult neurologist working primarily with non-learning disabled
patients, with limited experience of Rett syndrome. Another was a
paediatric neurologist, working with children both with and
without intellectual disabilities. The third was a psychiatrist in
intellectual disability, working mostly with people with intellec-
tual disability and epilepsy. For each case the reviewer was asked
to classify the seizure type. This led to one of the following
outcomes:
a. Agreement or disagreement that the events were seizures.
b. Agreement or disagreement that the patient had epilepsy.
c. Agreement or disagreement that the events were non-epileptic
vacant spells.
where there was disagreement, the majority view was
accepted.
2.2. Analysis
Initial analysis was performed using chi square tests, but where
patient numbers were insufﬁcient to show clinical differences
between phenotype, descriptive data were presented.
3. Results
The parents or carers of 89 patients (65%) responded to the
questionnaire. All were female and aged between 5 and 43 years.
Sixty of the 89 (67%) received a diagnosis of epilepsy. A total of 199
‘‘episodes’’ were reported as epileptic seizures by the parents or
carers of 60 girls. All three epileptologists agreed with the
diagnosis of epileptic seizures in 93 of the 199 reported ‘‘episodes’’
(47%) and in the remainder a majority view was taken, i.e., if 2 out
of 3 epileptologists agreed that it was an epileptic seizure, then it
was classiﬁed as one. There was also similar agreement that 66 of
the 89 patients (74%) had non-epileptic vacant spells. There was
most variation in the differentiation of non-epileptic vacant
spells.
The following data uses the consensus seizure classiﬁcation
agreed, following discussion between the three epileptologists.
3.1. Seizure type and syndrome
62% of patients had generalised tonic–clonic seizures, approxi-
mately a quarter had secondarily generalised tonic–clonic seizures,
and a quarter had complex partial seizures. Symptomatic focal
epilepsy (58%) was more common than symptomatic generalised
epilepsy (38%) (Tables 1 and 3).
There was a family history of Rett syndrome in three of the 89
patients, of epilepsy in six of the 89, and of intellectual disability
(other than Rett syndrome) in a further six. About three-quarters of
Table 1
Prevalence of seizure types, epilepsy syndromes and non-epileptic vacant spells listed by MECP2 mutation.
Mutation C terminal
deletion,
after TRD
(Transcription
Repression
Domain)
p.R133C,
c.397C>T
p.R106W,
c.316C>T
p.R168X,
c.502C>T
p.R255X,
c.763C>T
p.R270X,
c.808C>T
p.R294X,
c.880C>T
p.R306C,
c.916C>T
p.T158M,
c.473C>T
Number 15 10 3 19 11 8 2 10 11
Number with epilepsy 7 (47%) 6 (60%) 2 (66%) 13 (68%) 7 (64%) 8 (100%) 1 (50%) 8 (80%) 8 (73%)
Non-epileptic vacant spells 11 (73%) 9 (90%) 3 (100%) 14 (74%) 8 (73%) 6 (75%) 2 (100%) 5 (50%) 8 (73%)
Generalised tonic–clonic 4 4 0 12 4 5 0 4 4
Secondarily generalised tonic–clonic 2 1 2 1 1 0 0 5 3
Complex partial seizures without
secondary generalisation
0 2 1 1 1 3 1 2 5
Tonic 1 0 0 0 1 0 0 0 0
Atonic 0 0 0 0 0 0 0 1 0
Absence seizures 0 0 1 0 0 0 0 0 0
Myoclonic 0 0 0 0 0 0 1 0 0
Symptomatic generalised epilepsy 1/7 (14%) 2/6 (33%) 0/2 6/13 (46%) 4/7 (57%) 2/8 (25%) 1/1 (100%) 4/8 (50%) 3/8 (38%)
Symptomatic focal epilepsy 6/7 (86%) 4/6 (67%) 1/2 (50%) 7/13 (54%) 3/7 (43%) 5/8 (63%) 0/1 4/8 (50%) 5/8 (63%)
Diagnosis not possible 0 0 1/2 (50%) 0 0 1/8 (13%) 0 0 0
Table 2
Other clinical features listed by MECP2 mutation.
Mutation C terminal
deletion,
after TRD
(Transcription
Repression
Domain)
p.R133C,
c.397C>T
p.R106W,
c.316C>T
p.R168X,
c.502C>T
p.R255X,
c.763C>T
p.R270X,
c.808C>T
p.R294X,
c.880C>T
p.R306C,
c.916C>T
p.T158M,
c.473C>T
Number 15 10 3 19 11 8 2 10 11
Family history of epilepsy in
1st or 2nd degree relatives
1 2 0 1 1 0 0 0 1
Family history of Rett syndrome
in 1st or 2nd degree relatives
0 1 0 2 0 0 0 0 0
Family history of intellectual
disability in 1st or 2nd degree
relatives (excluding Rett
syndrome)
1 1 0 1 0 0 0 2 1
Patients currently or previously
taking antiepileptic medication
(AED)
10/15 (67%) 7/10 (70%) 2/3 (66%) 13/19 (68%) 9/11 (82%) 7/8 (88%) 1/2 (50%) 8/10 (80%) 9/11 (82%)
Patients currently taking AED 8/15 6/10 2/3 12/19 8/11 7/8 1/2 8/10 7/11
Patients taking one AED 7/8 (88%) 5/6 (83%) 2/2 (100%) 7/12 (58%) 4/8 (50%) 3/7 (43%) 1/1 (100%) 2/8 (25%) 4/7 (57%)
Mean age of ﬁrst seizure 4 years,
11 months
2 years,
8 months
2 years 5 years,
7 months
4 years,
5 months
4 years,
10 months
3 years 8 years 4 years,
7 months
Prevalence of carer-reported
breath-holding, hyperventilation
or air-swallowing
13/15 (87%) 8/10 (80%) 3/3 (100%) 12/19 (63%) 10/11(91%) 7/8 (88%) 2/2 (100%) 9/10 (90%) 9/11 (82%)
Association of carer reported
breath-holding, hyperventilation
or air-swallowing, with epilepsy
2/7 (29%) 0/5 2/2 (100%) 10/13 (77%) 6/7 (86%) 7/8 (88%) 1/1 (100%) 8/8 (100%) 7/8 (88%)
Table 3
Prevalence of seizure types and epilepsy syndromes.
Number (n = 60) Percentage (%)
Seizure type
Generalised tonic–clonic 37 62
Secondarily generalised
tonic–clonic
15 25
Complex partial 16 27
Tonic 2 3.3
Atonic 1 1.6
Absence seizures 1 1.6
Myoclonic 1 1.6
Epilepsy type
Symptomatic generalised 23 38.3
Symptomatic focal 35 58.3
Diagnosis not possible 2 3.3
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remained on them, including 59% on monotherapy (Table 2).
The age of ﬁrst epileptic seizure ranged from 2 to 8 years, and
differed between the classes of mutation (Table 2). The vast
majority of carers reported that individuals had breath holding,
hyperventilation or air swallowing. They also felt that there was an
association between these and epilepsy (Table 2).
3.2. Association between genotype and epileptic seizure classiﬁcation
Different mutations of the MECP2 gene showed a prevalence of
epileptic seizures varying between 47% and 100%, and of non-
epileptic vacant spells between 50% and 100%; the group numbers
were small and the differences not statistically signiﬁcant (using
chi-square analysis) (Table 1).
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We have found a prevalence of epilepsy of 67% among a large
cohort of Rett syndrome patients. Within this population, the
epilepsy prevalence varied between 47% and 100% with the type of
MECP2 mutation. We also identiﬁed difﬁculty in accurately
classifying seizure type, especially vacant episodes. This is
important as, although seizure description is the mainstay of
epilepsy diagnosis, it appears insufﬁcient in the case of Rett
syndrome.
The study has several shortcomings. We assessed responses to a
questionnaire and so risked ascertainment bias, possibly over-
representing epilepsy prevalence. Seizure diagnosis was based
upon written and verbal reports and we did not have video or
telemetry available. Also, there was no gold standard (and
disagreement among clinicians) over what constituted either an
epileptic seizure or a non-epileptic vacant spell.
These diagnostic difﬁculties, together with the relatively small
numbers of patients in each of the MECP2 mutation groups, may
have prevented us from identifying signiﬁcant phenotype–geno-
type associations. Nevertheless, this was a relatively large study of
an uncommon condition, and we believe it is one of very few
studies to attempt to identify an association between the type of
the Rett MECP2 mutation and the features of its epileptic seizures
and epilepsy, as determined by epileptologists.One previous study
concluded that epileptic seizure frequency in Rett syndrome was
inﬂuenced by mutation type and that epileptic seizure rates were
lower in those with C-terminal mutation and p.R294X mutation.13
This is similar to our ﬁndings. Jian et al.13 also suggested that those
with the most distal of these mutations also had a signiﬁcantly
reduced epileptic seizure onset in the ﬁrst four years of life.
However, episodes of epileptic seizures in this study were reported
by families over a period of one year and potentially may have been
misreported. R294X mutation was also associated with fewer
impairments, and R168X with more impairments in ambulation,
hand use and language.14 This seems to reﬂect the epileptic seizure
prevalence seen in our study (50% and 68% respectively).
The non-epileptic vacant episode was a feature of our study.
Clinical experience was used rather than investigation to identify
these events, but this is the norm in adult epileptology, at least at
an early stage of investigation. It is clear that the ability for non-
epileptic vacant spells to mimic absence seizures or complex
partial seizures, is an important clinical pointer. Future studies and
clinical practice will need to use video telemetry and possibly
autonomic monitoring, in pursuit of diagnostic accuracy. Their
under use in epilepsy services suggests, that epilepsy in patients
with Rett syndrome may be misdiagnosed and mistreated.
We recommend the development of a clear standard such as
video telemetry or prolonged video telemetry with polygraphy, to
differentiate epileptic seizures from non-epileptic vacant spells.
Prolonged video EEG may be done with additional respiratory
movement, end-tidal CO2 and electrocardiography (ECG).
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